Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
The Oncologist|November 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsTony Z Zhuang, Deepak Ravindranathan, Yuan Liu, et al.Journal of Immunotherapy and Precision Oncology|January 15, 2025
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution ExperienceTony Z Zhuang, Subir Goyal, Katherine B Case, et al.Cancers|December 23, 2023
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 ExpressionAgreen Hadadi, Harris B Krause, Andrew Elliott, et al.Cancer|August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkersBassel Nazha, Tony Zhuang, Sharon Wu, et al.Journal for Immunotherapy of Cancer|January 11, 2021
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II studySuchita Pakkala, Kristin Higgins, Zhengjia Chen, et al.The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.Cancer|July 3, 2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiationDylan J Martini, Katherine B Case, Derrik Gratz, et al.Cancer|April 16, 2026
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Yuan Liu, et al.Therapeutic Advances in Medical Oncology|February 13, 2025
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitorsAhmet Yildirim, Mengting Wei, Yuan Liu, et al.Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.Pageof 6